Clinical Trial Update: IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravenous iron with an SGLT2 inhibitor on ventricular function and myocardial iron content in patients with heart failure an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency

Drugs mentioned

• Intravenous iron
• SGLT2 inhibitor

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Heart Failure, Systolic, Iron Deficiencies | Phase 3 | Status: NOT_YET_RECRUITING